Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves Genentech’s Actemra for giant cell arteritis

cphi-onlineMay 25, 2017

Tag: cell arteritis , Genentech

PharmaSources Customer Service